NORTHERN CLINICS OF ISTANBUL, cilt.8, sa.2, ss.145-149, 2021 (ESCI, TRDizin)
OBJECTIVE: This study aims to demonstrate real-life effectiveness of dupilumab treatment in moderate-to-severe atopic dermatitis patients.